Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED

大健康國際集團控股有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 2211) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2016 INTERIM RESULTS HIGHLIGHTS Six months ended 30 June 2016 2015

RMB Million

(Unaudited)

RMB Million

(Unaudited)

Change

(%)

Revenue

1,903.8

2,570.9

-25.9

Gross profit

519.8

736.1

-29.4

Operating profit

115.3

331.0

-65.2

Profit for the period

87.4

248.4

-64.8

EBITDA

138.1

354.2

-61.0

Basic earnings per share - RMB cents

4.12

12.34

-66.6

Gross margin (%)

27.3

28.6

-1.3pp

Operating margin (%)

6.1

12.9

-6.8pp

Net margin (%)

4.6

9.7

-5.1pp

The board of directors (the "Board") of Universal Health International Group Holding Limited (the "Company") is pleased to announce the unaudited interim results of the Company and its subsidiaries (collectively, the "Group") for the six months ended 30 June 2016 (the "Period") together with the comparative figures for the corresponding period in 2015 as follows:

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited) Six months ended 30 June

Note

2016

RMB'000

2015

RMB'000

Revenue

2

1,903,845

2,570,945

Cost of sales

3

(1,384,006)

(1,834,871)

Gross profit

519,839

736,074

Selling and marketing expenses

3

(360,367)

(358,813)

Administrative expenses

3

(45,374)

(46,628)

Other income

1,668

414

Other losses - net

(417)

(10)

Operating profit

115,349

331,037

Finance income

4

7,192

4,523

Finance costs

4

(2,721)

(4,632)

Finance income/(costs) - net

4

4,471

(109)

Share of post-tax profits of joint ventures

441

545

Share of loss of an associate

(59)

-

Profit before income tax

120,202

331,473

Income tax expenses

5

(32,803)

(83,098)

Profit for the period

87,399

248,375

Profit attributable to:

- Owners of the Company

85,837

244,678

- Non-controlling interests

1,562

3,697

87,399

248,375

Earnings per share attributable to owners of the Company for the period (RMB cents)

- Basic and diluted

6

4.12

12.34

Other comprehensive loss

Item that may be reclassified to profit or loss

Currency translation differences

(2,249)

-

Total comprehensive income for the period

85,150

248,375

Total comprehensive income attributable to:

- Owners of the Company

83,588

244,678

- Non-controlling interests

1,562

3,697

85,150

248,375

CONDENSED CONSOLIDATED STATEMENT OF BALANCE SHEET

Note

(Unaudited)

As at 30 June

2016

RMB'000

(Audited)

As at 31 December

2015

RMB'000

ASSETS

Non-current assets

Property, plant and equipment

109,436

103,167

Land use rights

3,666

3,713

Intangible assets

662,119

672,055

Investments in joint ventures

7,961

7,520

Investments in an associate

243,017

-

Deferred income tax assets

14,042

19,297

Total non-current assets

1,040,241

805,752

Current assets

Trade and other receivables

8

354,845

442,853

Inventories

371,745

398,605

Restricted cash

207,228

227,414

Cash and cash equivalents

1,515,961

1,333,320

Total current assets

2,449,779

2,402,192

Total assets

3,490,020

3,207,944

EQUITY

Equity attributable to owners of the Company

Share capital

14,878

12,259

Other reserves

1,530,589

1,319,669

Retained earnings

1,342,559

1,256,722

2,888,026

2,588,650

Non-controlling interests

31,282

29,720

Total equity

2,919,308

2,618,370

(Unaudited) (Audited) As at 30 June

As at 31 December

LIABILITIES Non-current liabilities 2016 2015

Note RMB'000 RMB'000

Deferred income tax liabilities 43,940 46,585

Current liabilities

Borrowings

173,330

166,920

Trade and other payables

9

349,424

373,464

Current income tax liabilities

4,018

2,605

Total current liabilities

526,772

542,989

Total liabilities

570,712

589,574

Total equity and liabilities

3,490,020

3,207,944

Jintian Pharmaceutical Group Ltd. published this content on 25 August 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 25 August 2016 05:44:08 UTC.

Original documenthttp://www.jtyyjt.com/d/file/touzizheguanxi/gonggaojigonghan/2016/2016-08-25/d3ec50053e6b932285380929a63763fd.pdf

Public permalinkhttp://www.publicnow.com/view/A4AB755C5ACF42743FAD86EA8EA7B251AEA825DC